Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

HIZIN 25 TABLET 25 mg - HSA Drug Approval Details

Approvals/HSA/HIZIN 25 TABLET 25 mg

Approved

THERAPEUTIC

HIZIN 25 TABLET 25 mg

OLIC (THAILAND) LTD🇸🇬 Health Sciences Authority

Approval Date: Jun 16, 1989
Approval ID: 8a2e90b29cdc4707
Company: OLIC (THAILAND) LTD
Type: Therapeutic

Approval Details

Approval Id: 8a2e90b29cdc4707
Drug Name: HIZIN 25 TABLET 25 mg
Product Name: HIZIN 25 TABLET 25 mg
Approval Number: SIN03422P
Approval Date: 1989-06-16
Registrant: UNI DRUG HOUSE
Licence Holder: UNI DRUG HOUSE
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: TABLET
Route Of Administration: ORAL
Atc Code: N05BB01
Atc Item Name: hydroxyzine
Pharma Manufacturer Name: UNI DRUG HOUSE SDN. BHD.
Company Detail Path: /organization/uni-drug-house-sdn-bhd

Active Ingredients

HYDROXYZINE HCl

25 mg

HYDROXYZINE HCl

25 mg

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jun 16, 1989

Approval ID

8a2e90b29cdc4707

Type

Therapeutic

Back to HSA Approvals